Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

The employee equity awards vest over four years, with 25% of each grant vesting annually.

Rhea-AI Summary

Rigel Pharmaceuticals (Nasdaq: RIGL) granted 35,275 restricted stock units as employment inducements to non-executive employees under its Inducement Plan.

The awards cover 18 employees and vest over four years, with 25% vesting each year. Rigel's Board Compensation Committee approved the awards, which were granted in accordance with NASDAQ Listing Rule 5635(c)(4).

Positive

• None.

Negative

• Minor point. Forward-looking: it has not happened yet and may not happen.35,275 restricted stock units granted to 18 non-executive employees create potential dilution as they vest over four years.

Key Figures

Restricted stock units granted: 35,275 restricted stock units Recipients: 18 employees Vesting period: 4 years +1 more

Restricted stock units granted

35,275 restricted stock units

Inducement awards to non-executive employees

Recipients

18 employees

Non-executive employees entering employment with Rigel

Vesting period

4 years

Restricted stock unit grants

Annual vesting tranche

25%

Of the grant vesting each year

Historical Context

1 past event · Latest: Jul 07

1 event

1. Jul 07

   Inducement grants

   24h Move

   +5.7%

   Granted restricted stock units to new employees under the same plan, with the same four-year vesting schedule.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

restricted stock units, nasdaq listing rule 5635(c)(4)

2 terms

restricted stock units financial

"Rigel granted 35,275 restricted stock units to 18 non-executive employees"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

nasdaq listing rule 5635(c)(4) regulatory

"in accordance with NASDAQ Listing Rule 5635(c)(4)"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, Calif., Oct. 2, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc. Inducement Plan, approved by the Compensation Committee of Rigel's Board of Directors and granted as an inducement material to employees entering into employment with Rigel, in accordance with NASDAQ Listing Rule 5635(c)(4). Specifically, Rigel granted 35,275 restricted stock units to 18 non-executive employees vesting over four years with 25% of the grant vesting each year.

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, its marketed products and pipeline of potential products, please visit www.rigel.com.

Contact for Investors & Media
Rigel Pharmaceuticals, Inc. 
650.624.1232
ir@rigel.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-pharmaceuticals-inc-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302896740.html

SOURCE Rigel Pharmaceuticals, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many restricted stock units did Rigel grant, and how do they vest?

Rigel granted 35,275 restricted stock units to 18 non-executive employees, vesting over four years with 25% of the grant vesting each year. The awards were employment inducements under Rigel's Inducement Plan.